Advanced search
Publication Cover
Modern Rheumatology Volume 23, 2013 - Issue 3
Journal homepage
23
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Serum level of APRIL/BLyS in Behçet’s disease patients: clinical significance in uveitis and disease activity

Tamer A. GheitaDepartment of Rheumatology, Faculty of Medicine, Cairo University, Cairo 12613, EgyptCorrespondence[email protected]
,
Hala RaafatDepartment of Rheumatology, Faculty of Medicine, Cairo University, Cairo 12613, Egypt
,
Hossam KhalilDepartment of Ophthalmology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
&
Hani HusseinDepartment of Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt
Pages 542-546 | Received 28 Mar 2012, Accepted 31 May 2012, Published online: 02 Jan 2014

REFERENCES

  • Sadreddini S, Noshad H, Molaeefard M, Noshad R. Treatment of retinal vasculitis in Behçet's disease with rituximab. Mod Rheumatol. 2008;18(3):306–8.
  • Davatchi F, Shams H, Rezaipoor M, Sadeghi-Abdollahi B, Shahram F, Nadji A, et al. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). Int J Rheum Dis. 2010;13(3):246–52.
  • Yazici H. The place of Behçet's syndrome among the autoim-mune diseases. Int Rev Immunol. 1997;14(1):1–10.
  • Charteris DG, Barton K, McCartney AC, Lightman SL. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmu-nity. 1992;12(3):201–6.
  • Treusch M, Vonthein R, Baur M, Gfinaydin I, Koch S, Stfibiger N, et al. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford). 2004;43(10):1275–82.
  • Suh CH, Park YB, Song J, Lee CH, Lee SK. Oligoclonal B lymphocyte expansion in the synovium of a patient with Behçet's disease. Arthritis Rheum. 2001;44(7):1707–12.
  • EkOoglu-Demiralp E, Kibaroglu A, Direskeneli H, Yavuz S, Karsli F, Yurdakul S, et al. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets. J Rheu-matol. 1999;26(4):826–32.
  • Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C. New ELISA for B cell-activating factor. Clin Chem. 2009;55(10):1843–51.
  • Krivosikova M, Dallos T, Maslinski W, Buc M. B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases. Bratisl Lek Listy. 2009;110(3):137–45.
  • Hamzaoui K, Houman H, Ben Dhifallah I, Kamoun M, Hamzaoui A. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease. Clin Exp Rheumatol. 2008;26[4 Suppl 50]:S64–71.
  • Gheita TA, Bassyouni IH, Emad Y, El-Din AM, Abdel-Rasheed E, Hussein H. Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity. Jt Bone Spine. 2012;79(3):285–90.
  • Hirohata S. Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci. 2008;267(1-2):41–7.
  • Hamzaoui K, Houman H, Hentati F, Hamzaoui A. BAFF is up-regulated in central nervous system of neuro-Behçet's disease. J Neuroimmunol. 2008;200(1-2):111–4.
  • Hamzaoui A, Chelbi H, Sassi FH, Hamzaoui K. Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement. Oxid Med Cell Longev. 2010;3(2):122–8.
  • Suzuki N, Sakane T, Ueda Y, Tsunematsu T. Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum. 1986;29(2):212–9.
  • International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disaese. Lancet. 1990;335:1078–80.
  • Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38(8): 728–33.
  • Zamir E, Bodaghi B, Tugal-Tutkun I, See RF, Charlotte F, Wang RC, et al. Conjunctival ulcers in Behçet's disease. Ophthalmol-ogy. 2003;110(6):1137–41.
  • Belfort R Jr, Moura NC, Mendes NF. T and B lymphocytes in the aqueous humor of patients with uveitis. Arch Ophthalmol. 1982;100(3):465–7.
  • Fawzy SM, Gheita TA, El-Nabarawy E, El-Demellawy HH, Shaker OG. Serum BAFF level and its correlations with various disease parameters in patients with systemic sclerosis and sys-temic lupus erythematosus. Egypt Rheumatol. 2011;33(1):45–51.
  • Kiyama K, Kawabata D, Hosono Y, Kitagori K, Yukawa N, Yoshifuji H, et al. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther. 2012;14(2):R86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.